FCS Press Releases

Florida Cancer Specialists & Research Institute is driving critical conversations at the Florida Society of Clinical Oncology 2025 Business of Oncology Summit.

Florida Cancer Specialists & Research Institute expands availability of radiopharmaceutical therapies for cancer patients.

FCS Director of Late-Phase Research Bradley Monk, MD authors publications highlighting new targeted therapies for cervical cancer.

FCS participation in the FLASCO Fellow and Resident Training event promotes development of the new oncology physicians.

FCS real-world evidence presented in abstract at MOASC 2025 Annual Oncology Summit & Research Symposium.

FCS welcomes board-certified medical oncologist and hematologist Raju Vaddepally, MD.

FCS is partnering with Research to Practice® for the Fourth Annual National General Medical Oncology Summit in Miami.

Shijia Zhang, MD, PhD, joins Florida Cancer Specialists & Research Institute in Hillsborough County.

FCS celebrates opening of new facility in Altamonte Springs with a ribbon-cutting ceremony.

FCS achieved double-digit growth in early-phase clinical trials conducted at its three Drug Development Units (DDUs) in 2024.

Newly-published abstract highlights the evolution of treatments for cervical cancers across all stages, brought about through clinical trials.

Florida Cancer Specialists & Research Institute research featured at the 2025 American Society of Clinical Oncology (ASCO®) GI and ASCO GU events.

FCS Institute welcomes Hassan Hasanein, MD who will begin seeing patients at its new Wesley Chapel office upon opening.

NCODA announces the appointment of Florida Cancer Specialists & Research Institute President & Managing Physician Lucio N. Gordan, MD, to its Board of Directors.

Florida Cancer Specialists & Research Institute appoints Maen Hussein, MD as medical director of value-based care.

FCS receives Press Ganey 2024 Human Experience (HX) Guardian of Excellence Award® as a top provider in patient experience.